- Home
- GIFT vs BLRX Comparison
GIFT vs BLRX Comparison
Compare GIFT & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GIFT | BLRX |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.0M | 12.0M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | GIFT | BLRX |
|---|---|---|
| Price | $0.71 | $2.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $19.00 |
| AVG Volume (30 Days) | ★ 28.3K | 19.4K |
| Earning Date | 05-14-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.05 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $83,181,716.00 | N/A |
| Revenue This Year | $8.19 | N/A |
| Revenue Next Year | $10.30 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.58 | $2.15 |
| 52 Week High | $1.29 | $4.56 |
Technical Indicators
Market Signals| Indicator | GIFT | BLRX |
|---|---|---|
| Relative Strength Index (RSI) | 31.42 | 40.14 |
| Support Level | N/A | $2.18 |
| Resistance Level | $1.07 | $2.51 |
| Average True Range (ATR) | 0.07 | 0.16 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 32.01 | 2.12 |
Price Performance
Historical ComparisonAbout GIFT RDE Inc.
Giftify Inc operates in the incentive and rewards industry with a focus on retail, dining, and entertainment experiences, as the owner and operator of digital platforms, CardCash.com, Restaurant.com, and Takeout7.com. CardCash.com is a secondary gift card exchange platform, allowing consumers and retailers to buy and sell gift cards at various scales from several retailers; Restaurant.com is a restaurant-focused digital deals brand, connecting digital consumers and businesses by offering dining, retail, and entertainment deal options at several restaurants and retailers; and Takeout7 is a restaurant technology company offering online ordering solutions and AI-powered digital marketing services. Giftify has one segment, the sale of gift cards and discount certificates to its customers.
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.